005250 fundamentals

Green Cross Holdings Corp. engages in the manufacture of pharmaceutical products. It establishes and coordinates business strategies for Green Cross subsidiaries that launch business and investment portfolio management. Its products include prescription drugs such as blood derivatives, cerebrovascular disease treatment, fibrinolytic agent, vaccines, hunter syndrome drug, herbal medicine, and recombinant. It also offers over the counter drugs such as skin disease treatment and topical non-steroidal anti-inflammatories. The company was founded on October 5, 1967 and is headquartered in Yongin-si, South Korea.